The vector of anti-gp100 T cell receptor (TCR) is constructed for the engineering of T cell to target Human gp100. The T cells are genetically modified through transduction with a retroviral vector expressing gp100-specific T cell receptor. And the vector product was designed for the treatment of melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|TCR-L027Z||Human anti-gp100 (aa280-288) T cell receptor, pCDTCR1|
|TCR-L023||Mouse anti-PMEL17 (KTWGQYWQV) T Cell Receptor, pMSGV1|
|TCR-L031||Murinized (from Human) anti-PMEL17 (KTWGQYWQV) T Cell Receptor, pMSGV1|
|TCR-L024Z||Human anti-gp100 (aa208-217) T cell receptor, pCDTCR1|
|TCR-L030Z||Human anti-gp100 (aa280-288) T cell receptor (Cysteine-modiﬁed TCR), pCDTCR1|
|TCR-L027||Human anti-PMEL17 (YLEPGPVTA) T Cell Receptor, pMSGV1|
|TCR-L026Z||Murinized anti-gp100 (aa208-217) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|TCR-L031Z||Murinized anti-gp100 (aa154-162) T cell receptor, pCDTCR1|
|TCR-L030||Human anti-PMEL17 (YLEPGPVTA) T Cell Receptor, pGMT7|
|TCR-L028||Mouse anti-PMEL17 [154-162] T Cell Receptor, pMSGV1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved